Natalizumab treatment reduces endothelial activity in MS patients

A Randomized, Placebo-Controlled Trial of Natalizumab for Relapsing Multiple Sclerosis

Chris H. Polman, Paul O’Connor, Eva Havrdová et al. · New England Journal of Medicine · 2006 · 3.3K citations · Full text

Prevention of experimental autoimmune encephalomyelitis by antibodies against α4βl integrin

Ted Yednock, Catherine Cannon, Lawrence C. Fritz et al. · Nature · 1992 · 1.7K citations

Autoimmune Disease, Allergy, Autoantibody Production +10

A Controlled Trial of Natalizumab for Relapsing Multiple Sclerosis

David H. Miller, Omar Khan, William Sheremata et al. · New England Journal of Medicine · 2003 · 1.2K citations · Full text

Progressive Multifocal Leukoencephalopathy Complicating Treatment with Natalizumab and Interferon Beta-1a for Multiple Sclerosis

Bette K. Kleinschmidt‐DeMasters, Kenneth L. Tyler · New England Journal of Medicine · 2005 · 1.1K citations · Full text

Neurological Disorder, Immunology, Clinical Neurology +16

Progressive Multifocal Leukoencephalopathy after Natalizumab Therapy for Crohn's Disease

Gert Van Assche, Marc Van Ranst, Raf Sciot et al. · New England Journal of Medicine · 2005 · 1.1K citations · Full text

Rheumatoid Disorder, Autoimmune Disease, Medicine +15